Logistic regression analyses indicated that higher SETBP1 expression in GC was significantly associated with age (odds ratio [OR]=1.541 for ≥65 vs. <65, P=0.041), tumor differentiation (OR = 0.490 for poor vs. well or moderate, P=0.001), pathological stage (OR=2.679 for stage II vs. stage I, P=0.005; OR=2.118 for stage III vs. stage I, P=0.026; OR=2.912 for stage IV vs. stage I, P=0.015), T stage (OR=3.750 for T2 vs. T1, P=0.029; OR=3.329 for T3 vs. T1, P=0.039; OR=5.625 for T4 vs. T1, P=0.004; Table 3). The gene discussed is SETBP1; the disease is neoplasm.